CLSD icon

Clearside Biomedical
CLSD

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$75
1,879% upside
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Daniil Gataulin
0% 1-yr CLSD win rate
18 Jul ‘25 3 months ago